Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus

NCT02194400 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Resolve Therapeutics